MedTrace Logo

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

NCT04084730 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2025-09-16

No results posted yet for this study

Summary

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS who have had a lumpectomy procedure.

Conditions

  • Invasive Ductal Breast Carcinoma
  • Invasive Ductal Carcinoma, Breast
  • DCIS
  • DCIS Grade 1
  • DCIS Grade 2
  • Breast Cancer

Interventions

RADIATION

Accelerated Partial Breast Irradiation

Treatment will consist of APBI delivered using external beam RT techniques to a dose of 24 Gy in 3 fractions of 8.0 Gy delivered on consecutive weekdays

Sponsors & Collaborators

Principal Investigators

  • Atif J Khan, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-30
Primary Completion
2026-08-30
Completion
2026-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04084730 on ClinicalTrials.gov